Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy

References

• Kucharczyk MJ, Parpia S, Walker-Dilks C, Banfield L, Swaminath A. Ablative therapies in metastatic breast cancer: a systematic review. Breast Cancer Res Treat. 2017;164(1):13–25. doi:10.1007/s10549-017-4228-228401364
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
   PubMed Web of Science ®Google Scholar
• Shreya AB, Raut SY, Managuli RS, Udupa N, Mutalik S. Active targeting of drugs and bioactive molecules via oral administration by ligand-conjugated lipidic nanocarriers: recent advances. AAPS PharmSciTech. 2019;20(1):20. doi:10.1208/s12249-018-1262-230604109
   PubMedGoogle Scholar
• Wijdeven RH, Pang B, Assaraf YG, Neefjes J. Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics. Drug Resist Updat. 2016;28:65–81. doi:10.1016/j.drup.2016.07.00127620955
   PubMed Web of Science ®Google Scholar
• Mahmoudi K, Garvey KL, Bouras A, et al. 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas. J Neurooncol. 2019;141(3):595–607. doi:10.1007/s11060-019-03103-430659522
   PubMed Web of Science ®Google Scholar
• Banerjee SM, MacRobert AJ, Mosse CA, Periera B, Bown SG, Keshtgar MRS. Photodynamic therapy: inception to application in breast cancer. Breast. 2017;31:105–113. doi:10.1016/j.breast.2016.09.01627833041
   PubMed Web of Science ®Google Scholar
• Yoon JH, Yoon HE, Kim O, Kim SK, Ahn SG, Kang KW. The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells. Lasers Surg Med. 2012;44(1):76–86. doi:10.1002/lsm.2115422246987
   PubMedGoogle Scholar
• Denkova AG, de Kruijff RM, Serra-Crespo P. Nanocarrier-mediated photochemotherapy and photoradiotherapy. Adv Healthc Mater. 2018;7(8):1701211. doi:10.1002/adhm.201701211
   Web of Science ®Google Scholar
• Biteghe FAN, Davids LM. A combination of photodynamic therapy and chemotherapy displays a differential cytotoxic effect on human metastatic melanoma cells. J Photochem Photobiol B. 2017;166:18–27. doi:10.1016/j.jphotobiol.2016.11.00427852006
   PubMedGoogle Scholar
• Kwiatkowski S, Knap B, Przystupski D, et al. Photodynamic therapy – mechanisms, photosensitizers and combinations. Biomed Pharmacother. 2018;106:1098–1107. doi:10.1016/j.biopha.2018.06.15530119176
   PubMed Web of Science ®Google Scholar
• Cheng CT, Castro G, Liu CH, Lau P. Advanced nanotechnology: an arsenal to enhance immunotherapy in fighting cancer. Clin Chim Acta. 2019;492:12–19. doi:10.1016/j.cca.2019.01.02730711524
   PubMed Web of Science ®Google Scholar
• Wang Z, Deng X, Ding J, Zhou W, Zheng X, Tang G. Mechanisms of drug release in pH-sensitive micelles for tumour targeted drug delivery system: a review. Int J Pharm. 2018;535(1–2):253–260. doi:10.1016/j.ijpharm.2017.10.06429113804
   PubMed Web of Science ®Google Scholar
• Zhou F, Teng F, Deng P, Meng N, Song Z, Feng R. Recent progress of nano-drug delivery system for liver cancer treatment. Anticancer Agents Med Chem. 2018;17(14):1884–1897. doi:10.2174/187152061766617071315114928707574
   PubMedGoogle Scholar
• Isoglu I, Ozsoy Y, Isoglu S. Advances in micelle-based drug delivery: cross-linked systems. Curr Top Med Chem. 2017;17(13):1469–1489. doi:10.2174/15680266170917021321410128017154
   PubMed Web of Science ®Google Scholar
• Maeki M, Kimura N, Sato Y, Harashima H, Tokeshi M. Advances in microfluidics for lipid nanoparticles and extracellular vesicles and applications in drug delivery systems. Adv Drug Deliv Rev. 2018;128:84–100. doi:10.1016/j.addr.2018.03.00829567396
   PubMed Web of Science ®Google Scholar
• Carazo E, Borrego-Sánchez A, García-Villén F, et al. Advanced inorganic nanosystems for skin drug delivery. Chem Rec. 2018;18(7–8):891–899. doi:10.1002/tcr.20170006129314634
   PubMed Web of Science ®Google Scholar
• Olov N, Bagheri-Khoulenjani S, Mirzadeh H. Combinational drug delivery using nanocarriers for breast cancer treatments: a review. J Biomed Mater Res A. 2018;106(8):2272–2283. doi:10.1002/jbm.a.3641029577607
   PubMed Web of Science ®Google Scholar
• Castillo RR, Colilla M, Vallet-Regí M. Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer. Expert Opin Drug Deliv. 2017;14(2):229–243. doi:10.1080/17425247.2016.121163727402029
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu M, Liu A, Zhai G. Advances in functionalized mesoporous silica nanoparticles for tumor targeted drug delivery and theranostics. Curr Pharm Des. 2017;23(23):3367–3382. doi:10.2174/138161282266616102515361927784244
   PubMedGoogle Scholar
• Wen J, Yang K, Liu F, Li H, Xu Y, Sun S. Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems. Chem Soc Rev. 2017;46(19):6024–6045. doi:10.1039/C7CS00219J28848978
   PubMed Web of Science ®Google Scholar
• Stöber W, Fink A, Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci. 1968;26(1):62–69. doi:10.1016/0021-9797(68)90272-5
   Web of Science ®Google Scholar
• Wang X, Zhang Y, Luo W, et al. Synthesis of ordered mesoporous silica with tunable morphologies and pore sizes via a nonpolar solvent-assisted stöber method. Chem Mater. 2016;28(7):2356–2362. doi:10.1021/acs.chemmater.6b00499
   Web of Science ®Google Scholar
• Mehravi B, Ardestani MS, Damercheli M, et al. Breast cancer cells imaging by targeting methionine transporters with gadolinium-based nanoprobe. Mol Imaging Biol. 2014;16(4):519–528. doi:10.1007/s11307-014-0733-424500771
   PubMedGoogle Scholar
• Shahabi S, Döscher S, Bollhorst T, et al. Enhancing cellular uptake and doxorubicin delivery of mesoporous silica nanoparticles via surface functionalization: effects of serum. ACS Appl Mater Interfaces. 2015;7(48):26880–26891. doi:10.1021/acsami.5b0948326562468
   PubMedGoogle Scholar
• Liang X, Wang X, Zhuang J, Chen Y, Wang D, Li Y. Synthesis of nearly monodisperse iron oxide and oxyhydroxide nanocrystals. Adv Funct Mater. 2006;16(14):1805–1813. doi:10.1002/(ISSN)1616-3028
   Web of Science ®Google Scholar
• Lattuada M, Hatton TA. Functionalization of monodisperse magnetic nanoparticles. Langmuir. 2007;23(4):2158–2168. doi:10.1021/la062092x17279708
   PubMed Web of Science ®Google Scholar
• Lee JE, Lee N, Kim H, et al. Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc. 2010;132(2):552–557. doi:10.1021/ja905793q20017538
   PubMedGoogle Scholar
• Shi S, Zhu X, Zhao Z, et al. Photothermally enhanced photodynamic therapy based on mesoporous Pd@Ag@mSiO2 nanocarriers. J Mater Chem B. 2013;1(8):1133. doi:10.1039/c2tb00376g
   PubMed Web of Science ®Google Scholar
• Zhan J, Ma Z, Wang D, et al. Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy. Int J Nanomed. 2017;12:2733–2748. doi:10.2147/IJN.S127528
   PubMed Web of Science ®Google Scholar
• Frey NA, Peng S, Cheng K, Sun S. Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage. Chem Soc Rev. 2009;38(9):2532. doi:10.1039/b815548h19690734
   PubMed Web of Science ®Google Scholar
• Zhou JL, Song F, Tian JF, Nie WC, Wang XL, Wang YZ. Electrostatic wrapping of doxorubicin with curdlan to construct an efficient pH-responsive drug delivery system. Nanotechnology. 2017;28(29):295601. doi:10.1088/1361-6528/aa75b528557808
   PubMed Web of Science ®Google Scholar
• Wang X, Zhuang J, Peng Q, Li Y. A general strategy for nanocrystal synthesis. Nature. 2005;437(7055):121–124. doi:10.1038/nature0396816136139
   PubMed Web of Science ®Google Scholar
• Wu B, Lu ST, Zhang LJ, Zhuo RX, Xu HB, Huang SW. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid–polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment. Int J Nanomed. 2017;12:1853–1862. doi:10.2147/IJN.S131235
   PubMed Web of Science ®Google Scholar
• Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK. Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng C. 2019;98:1252–1276. doi:10.1016/j.msec.2019.01.066
   PubMed Web of Science ®Google Scholar
• Gong C, Hu C, Gu F, et al. Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment. J Control Release. 2017;266:272–286. doi:10.1016/j.jconrel.2017.09.04228987884
   PubMed Web of Science ®Google Scholar
• Lin L, Xiong L, Wen Y, et al. Active targeting of nano-photosensitizer delivery systems for photodynamic therapy of cancer stem cells. J Biomed Nanotechnol. 2015;11(4):531–554.26310063
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhao X, Guo S, Lin T, Guo H. Highly effective photothermal chemotherapy with pH-responsive polymer-coated drug-loaded melanin-like nanoparticles. Int J Nanomed. 2017;12:1827–1840. doi:10.2147/IJN.S130539
   PubMed Web of Science ®Google Scholar
• Liu Y, Workalemahu B, Jiang X. The effects of physicochemical properties of nanomaterials on their cellular uptake in vitro and in vivo. Small. 2017;13(43):1701815. doi:10.1002/smll.v13.43
   Web of Science ®Google Scholar
• Li X, Wang L, She L, et al. Immunotoxicity assessment of ordered mesoporous carbon nanoparticles modified with PVP/PEG. Colloids Surf B Biointerfaces. 2018;171:485–493. doi:10.1016/j.colsurfb.2018.07.03630077906
   PubMed Web of Science ®Google Scholar
• Schmucker H, Blanding WM, Mook JM, et al. Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells. Cell Oncol. 2018;41(2):159–168. doi:10.1007/s13402-017-0363-3
   Web of Science ®Google Scholar
• Khayyat L, Essawy A, Sorour J, Soffar A. Tartrazine induces structural and functional aberrations and genotoxic effects in vivo. Peer J. 2017;5:e3041. doi:10.7717/peerj.304128243541
   PubMedGoogle Scholar